Emerging Microbes & Infections Best Paper Award
In the first month of each year, Editors-in-Chief of EMI will announce the selection of up to 4 papers published in the previous year based on the novelty, scientific significance, and potential impact to the clinical practice and global health in the field of emerging infectious diseases.
Winners of the Best Paper Award are listed in the collection below. For information on the prize-winning papers from 2019-2021, please view this document.
2022 Award Winners
First Place Award
Title: SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
Authors: Hanjun Zhao, Lu Lu, Zheng Peng, et al.
EMI comments: This report reveals the cellular mechanism why Omicron variants are less pathogenic than early SARS-CoV-2 variants.
Second Place Award
Title: Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
Authors: Jingwen Ai, Haocheng Zhang, Yi Zhang, et al.
EMI comments: This study showed that Omicron variants are less sensitive to neutralization even after boost vaccination.
Third Place Award - A
Title: Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters
Authors: Yan Xiang & Addison White
EMI comments: A timely and comprehensive virological review on Monkeypox
Third Place Award - B
Title: A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, et al.
EMI comments: Report of a novel mAb across SARS 1, SARS 2 and other sarbecoviruses.